Rethinking Superior Mesenteric Artery Syndrome: Insights Into Diagnosis and Therapeutic Strategies
Neurogastroenterology & Motility · 2026-11 · 38 (11)
DOI: 10.1111/nmo.70497 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurogastroenterology & Motility, online erschienen am 15.11.2026. Verfasst von Christian von Muhlenbrock und 5 weiteren Autor:innen. Beteiligte Einrichtung: Translational Research Center for Gastrointestinal Disorders (TARGID), KU Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Superior Mesenteric Artery Syndrome. Die Arbeit nennt 41 Literaturangaben.
Abstract (Originalsprache)
Background
The superior mesenteric artery (SMA) syndrome is reported as a rare cause of intestinal obstruction caused by vascular compression of the third part of the duodenum between the aorta and the SMA. Both medical and surgical treatments have been proposed, with different reported success rates. Our aim is t o assess the clinical features, imaging findings, and treatment outcomes of patients undergoing hypotonic barium duodenography (HBD) for suspected SMA syndrome and evaluate the effectiveness of medical and surgical treatments.
Methods
We conducted a retrospective cohort study of patients undergoing HBD for suspected SMA syndrome. HBD findings were compared with CT measurements of aortomesenteric distance (AMD) and angle (AMA). Results of antroduodenal manometry and gastric emptying tests were analyzed. Clinical outcomes were compared between medical and surgical management. Key Results Forty‐nine patients underwent HBD (33.2 ± 1.6 years; 84% female; BMI 17.5 kg/m 2 ) between 2003 and 2023. After excluding patients with a more likely alternative diagnosis, 11 patients met the predefined HBD criteria for SMA syndrome. Clinical characteristics did not differ between confirmed cases and the non‐confirmed patients (controls). AMA was significantly sharper in cases (18.8 ± 2.5 vs. 26.5 ± 2.1; p = 0.05), while AMD was similar (5 ± 2.2 vs. 7 ± 2.2 mm; p = 0.13). In the confirmed group, medical therapy ( n = 6) led to weight gain in 67% and symptom improvement in 50%; surgery ( n = 5) resulted in weight gain in 80% but symptom relief in only one patient (20%).
Conclusions
Conservative management should be the initial approach in suspected SMA syndrome. Careful diagnosis combined with structured medical therapy can yield clinical benefit while avoiding surgical risks. Prospective studies are needed to refine criteria for intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Translational Research Center for Gastrointestinal Disorders (TARGID), KU Leuven, Leuven, Belgium.
- Department of Internal Medicine, Center of Digestive Diseases, Clinica Universidad de los Andes, Santiago, Chile.
- Gastroenterology Section, Department of Medicine, Hospital Clinico Universidad de Chile, Santiago, Chile.
- Division of Gastroenterology, University Hospital Gasthuisberg, Leuven, Belgium.
- Division of Radiology, University Hospital Gasthuisberg, Leuven, Belgium.
ORCID-Profile: Christian von Muhlenbrock, Thomas Debrouwere, Tim Vanuytsel
Zitieren
APA
von Muhlenbrock, C., Abbeel, S., Debrouwere, T., Vanbeckevoort, D., Tack, J., & Vanuytsel, T. (2026). Rethinking Superior Mesenteric Artery Syndrome: Insights Into Diagnosis and Therapeutic Strategies. Neurogastroenterology & Motility, 38(11). https://doi.org/10.1111/nmo.70497
Vancouver
von Muhlenbrock C, Abbeel S, Debrouwere T, Vanbeckevoort D, Tack J, Vanuytsel T. Rethinking Superior Mesenteric Artery Syndrome: Insights Into Diagnosis and Therapeutic Strategies. Neurogastroenterology & Motility. 2026;38(11). doi:10.1111/nmo.70497
BibTeX
@article{vonMuhlenbrock2026,
author = {von Muhlenbrock, Christian and Abbeel, Sandrien and Debrouwere, Thomas and Vanbeckevoort, Dirk and Tack, Jan and Vanuytsel, Tim},
title = {Rethinking Superior Mesenteric Artery Syndrome: Insights Into Diagnosis and Therapeutic Strategies},
journal = {Neurogastroenterology & Motility},
year = {2026},
volume = {38},
number = {11},
doi = {10.1111/nmo.70497}
}
EUVIMED